Figure 5.
Serum miR‐21‐5p was elevated in elderly ICH patients and was associated with clinical outcomes. (a) Left frontal, temporal lobe cerebral haemorrhage, volume: 17.31 ml; (b) right temporal lobe haemorrhage, volume: 22.51 ml; (c) left basal ganglia cerebral haemorrhage, volume: 34.07 ml; (d) right frontal, parietal lobe cerebral haemorrhage, volume: 43.45 ml; (e) left thalamic cerebral haemorrhage, volume: 30.30 ml; (f) right parietal lobe cerebral haemorrhage, volume: 28.0 ml; (g) RT–PCR measured the serum miR‐21‐5p expression levels on days 1, 2, 3 and 7 from patients with cerebral haemorrhages (n = 20) and normal patients (n = 10); (h) serum miR‐21‐5p levels and haematoma volume were positively correlated in ICH patients; (i–j) Both NIHSS score and mRS score were correlated with serum miR‐21‐5p at 90 days in ICH patients